Evidence map›Paper›PMID 39966543›Full record

SynthesisScientific reports2025

Predictors of anemia among HIV-infected children in Ethiopia: systematic review and meta-analysis.

Desalegn Girma, Zinie Abita, Wubetu Agegnehu, Daniel Asmelash, Amanuel Adugna, Nigusie Shifera, Melsew Setegn Alie, Gossa Fetene Abebe

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Desalegn GirmaDepartment of Midwifery, College of Health Science, Mizan-Tepi University, Mizan-Teferi, Ethiopia. desegir@gmail.com.ORCID 0000-0003-0001-8553
Zinie AbitaDepartment of Public Health, College of Health Science, Mizan-Tepi University, Mizan-Teferi, Ethiopia.
Wubetu AgegnehuDepartment of Public Health, College of Health Science, Mizan-Tepi University, Mizan-Teferi, Ethiopia.
Daniel AsmelashDepartment of Medical Laboratory, College of Health Science, Mizan Tepi University, Mizan-Teferi, Ethiopia.
Amanuel AdugnaDepartment of Midwifery, College of Health Science, Mizan-Tepi University, Mizan-Teferi, Ethiopia.
Nigusie ShiferaDepartment of Public Health, College of Health Science, Mizan-Tepi University, Mizan-Teferi, Ethiopia.
Melsew Setegn AlieDepartment of Public Health, College of Health Science, Mizan-Tepi University, Mizan-Teferi, Ethiopia.
Gossa Fetene AbebeDepartment of Midwifery, College of Health Science, Mizan-Tepi University, Mizan-Teferi, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anemia continues to be one of the common complications among HIV-infected children. In Ethiopia, though there is a systematic review and meta-analysis study on anemia among HIV-infected children, it only disclosed the effect Highly Active Antiretroviral Treatment on HIV/AIDS-anemia comorbidity, and yet, the meta effect of other potential factors such as type of ART, presence of opportunistic infection, advanced stage of HIV/AIDS, and cotrimoxazole therapy on HIV/AIDS-anemia comorbidity have not been explored in the previous review. Therefore, this systematic review and meta-analysis aimed to identify the factors associated with anemia among HIV-infected children. Moreover, this study provides an up-to-date pooled estimate of anemia among HIV-infected children in Ethiopia. We systematically searched PubMed, HINARI, Science Direct, Cochrane Library, Google Scholar, and African Journals Online on February 3, 2024, to identify relevant primary research articles. The Briggs Institute (JBI) Checklist was used to check the quality of the original studies. Meta package for proportions (Metapro) was used to estimate the pooled prevalence of anemia among HIV-infected children using the random-effects model. Heterogeneity across studies was checked using the I-square test. Funnel plots visual inspection and Egger's tests were done to detect publication bias. The pooled prevalence of anemia among HIV-infected children in Ethiopia was 23.79% (95% CI 17.28, 31.81). Age < 7 years (OR 3.71, 95% CI 2.58; 5.33), advanced HIV disease (OR 2.78, 95% CI 2.00; 3.87), intestinal parasitic infection (OR 2.28, 95% CI 1.02; 5.09), poor ART treatment adherence (OR 1.96, 95% CI 1.23; 3.10), opportunistic infection (OR 2.81, 95% CI 1.59; 4.95), viral load > 1000 copies/ml (OR 4.29, 95% CI 2.28; 8.09), and zidovudine containing regimen (OR 5.07, 95% CI 2.41; 10.64) were identified as factors associated with a higher risk of anemia. Whereas, cotrimoxazole prophylaxis therapy (OR 0.49, 95% CI 0.35; 0.72) reduces the risk of anemia among HIV-infected children. In Ethiopia, anemia remains a public health concern among children living with HIV. Therefore, regular screening and management of anemia are important for HIV-infected children, particularly for those with advanced HIV disease, opportunistic infection, high viral load, and who are taking zidovudine-containing regimens for better clinical outcomes. Moreover, preventive chemotherapy (deworming) and counseling on infection prevention should be provided for children living with HIV to prevent parasitic infection.

Indexed as

AnemiaHIV InfectionsAntiretroviral Therapy, Highly ActiveChildEthiopiaHumansPrevalenceRisk FactorsAnemiaChildrenEthiopiaHIVMeta-analysisSystematic review

Identifiers

PMID39966543
PMCPMC11836374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.